Medicine and Dentistry
Heart Right Ventricle Failure
100%
Pulmonary Hypertension
70%
Right Ventricular Hypertrophy
64%
Semaxanib
32%
Right Ventricular Function
28%
Right Ventricle
28%
Echocardiography
26%
Heart Ventricle Remodeling
25%
Fibrosis
23%
Heart Output
23%
Hemodynamic
21%
Hypoxia
21%
Systolic Blood Pressure
20%
Antifibrotic Agent
19%
Pirfenidone
19%
Gene Expression
19%
Monocrotaline Pyrrole
19%
Mercaptopurine
19%
Experimental Pulmonary Hypertension
19%
Pneumonectomy
19%
3 Hydroxybutyric Acid
19%
Amine Oxidase (Flavin Containing) Isoenzyme A
19%
Vasodilatation
19%
Tricuspid Insufficiency
19%
Heart Muscle Contractility
19%
Ketone Bodies
19%
Cardiac Magnetic Resonance Imaging
14%
Diastolic Function
13%
Clorgiline
12%
Afterload
10%
Inferior Cava Vein Obstruction
9%
Blood Pressure
9%
Systemic Vascular Resistance
9%
Vascular Remodeling
9%
Body Weight
8%
Stroke Volume
8%
Cardiac Fibrosis
8%
Cardiac Muscle Cell
8%
Pulmonary Vasculature
8%
Heart Failure
7%
Intubation
6%
End-Systolic Volume
6%
Diastolic Dysfunction
6%
Sham Procedure
6%
Heart Right Ventricle Pressure
6%
Left Ventricle
5%
Placebo
5%
Muscle Contractility
5%
Pharmacology, Toxicology and Pharmaceutical Science
Heart Right Ventricle Failure
61%
Pulmonary Hypertension
59%
Semaxanib
32%
Heart Right Ventricle Hypertrophy
25%
Heart Ventricle Remodeling
22%
Hypoxia
21%
Antifibrotic Agent
19%
Experimental Pulmonary Hypertension
19%
Monocrotaline Pyrrole
19%
Mercaptopurine
19%
Pirfenidone
19%
Fibrosis
19%
Mouse
19%
Amine Oxidase (Flavin Containing) Isoenzyme A
19%
Tricuspid Valve Regurgitation
19%
Inferior Cava Vein Obstruction
14%
Clorgiline
12%
Vascular Remodeling
9%
Heart Muscle Fibrosis
8%
Wistar Rat
8%
Placebo
5%
Moroxydine
5%
Keyphrases
Monoamine Oxidase A (MAO-A)
19%
Right Ventricular-pulmonary Arterial Coupling
19%
Vasorelaxation
19%
Pressure Overload
19%
Monocrotaline Pyrrole
19%
Pneumonectomy
19%
Inferior Vena Cava Occlusion
11%
Sugen 5416
9%
Clorgyline
9%
Sugen-hypoxia
9%
Sprague-Dawley
7%
